CIK 0001850119
- Emerging growth company
Century Therapeutics, Inc.
Sign in to watch- Ticker
- IPSC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 842040295
- Phone
- +1 215-981-4000
- Business address
- 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,212
- in 5 filings
Net −$10,212. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-03 | Carr Douglas SVP Finance & Operations | Sale | −257 | $3.11 | $798 | 317,323 |
| 2024-05-03 | Farid Adrienne Chief Operations Officer | Sale | −913 | $3.11 | $3K | 137,236 |
| 2024-04-22 | Russotti Gregory | Sale 10b5-1 | −5,000 | $3.10 | $15K | 297,319 |
| 2024-03-07 | Pfeiffenberger Brent President and CEO | Grant or award | +17,425 | 1,470,704 | ||
| 2024-03-07 | Pfeiffenberger Brent President and CEO | Grant or award · Stock Option (right to buy) | +104,550 | 104,550 | ||
| 2024-03-07 | Carr Douglas SVP Finance & Operations | Grant or award | +14,000 | 317,580 | ||
| 2024-03-07 | Carr Douglas SVP Finance & Operations | Grant or award · Stock Option (right to buy) | +81,000 | 81,000 | ||
| 2024-03-07 | Russotti Gregory | Grant or award | +24,000 | 302,319 | ||
| 2024-03-07 | Russotti Gregory | Grant or award · Stock Option (right to buy) | +146,000 | 146,000 | ||
| 2024-03-07 | Farid Adrienne Chief Operations Officer | Grant or award | +24,000 | 138,149 | ||
| 2024-03-07 | Farid Adrienne Chief Operations Officer | Grant or award · Stock Option (right to buy) | +146,000 | 146,000 | ||
| 2024-03-07 | Levitsky Hyam President of R&D | Grant or award | +24,000 | 24,000 | ||
| 2024-03-07 | Levitsky Hyam President of R&D | Grant or award · Stock Option (right to buy) | +146,000 | 146,000 | ||
| 2024-03-07 | Farid Adrienne Chief Operations Officer | Exercise or conversion | +22,831 | $1.03 | $24K | 136,980 |
| 2024-03-07 | Farid Adrienne Chief Operations Officer | Sale | −22,831 | $5.14 | $117K | 114,149 |
| 2024-03-07 | Farid Adrienne Chief Operations Officer | Exercise or conversion · Stock Option (right to buy) | −22,831 | 168,655 | ||
| 2024-03-06 | Farid Adrienne Chief Operations Officer | Exercise or conversion | +30,684 | $1.03 | $32K | 144,833 |
| 2024-03-06 | Farid Adrienne Chief Operations Officer | Sale | −30,684 | $4.96 | $152K | 114,149 |
| 2024-03-06 | Farid Adrienne Chief Operations Officer | Exercise or conversion · Stock Option (right to buy) | −30,684 | 191,486 | ||
| 2024-02-16 | Farid Adrienne Chief Operations Officer | Exercise or conversion | +485 | $1.03 | $500 | 114,634 |
Page 7 of 12 · 233 trades